Results 11 to 20 of about 7,292 (203)
Minoxidil in trichological practice
Management of patients with alopecia is still a challenging task. Minoxidil is a pyrimidine derivative, a potent KATP channel opener, and has been shown to act as a vasodilating agent.
O. Yu. Olisova, I. P. Gostroverkhova
doaj +3 more sources
Infantile generalized hypertrichosis caused by topical minoxidil [PDF]
Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day ...
Greice Rampon +3 more
doaj +2 more sources
Application of topical minoxidil in acne vulgaris treatment
Background: Acne vulgaris (AV) results from increased sebum production and Cutibacterium acnes (C. acnes) overgrowth, leading to pilosebaceous unit inflammation.
Chun-Bing Chen +7 more
doaj +2 more sources
Pharmacological correction of retinal ischemia/reperfusion by minoxidil [PDF]
Introduction/Objective. The objective of this paper was to increase the effectiveness of pharmacological correction of retinal ischemia-reperfusion by using minoxidil. Methods. The research was carried out on 180 Wistar rats.
Peresypkina Anna A. +4 more
doaj +4 more sources
Thermogravimetric investigations of cream with minoxidil
Minoxidil is one of the most effective and modern medications, which is used in modern trichology for hair growth stimulation in case of androgenic and other forms of alopecia.
I. V. Gnitko +3 more
doaj +3 more sources
The study of consistent properties of gelatinous shampoo with minoxidil
The aim of the work is the study of consistent properties of gelatinous shampoo with minoxidil 1% for the complex therapy and prevention of alopecia. This shampoo with minoxidil was selected according to the complex physical-chemical, biopharmaceutical ...
I. V. Gnitko +3 more
doaj +2 more sources
EFECTIVITY MINOXIDIL AS A TREATMENT OF ALOPECIA AREATA
Alopecia areata is hair loss with patchy formation, the most common cause of alopecia nonscarring. Occurred in 1,7 % of Americans aged 50 years. Canoccurs in both sexes, all races and any age.
Wayan Evie Frida Yustin
doaj +1 more source
Farouk M Sakr,1 Ali MI Gado,2 Haseebur R Mohammed,2 Abdel Nasser Ismail Adam3 1Department of Pharmaceutics, 2Departments of Pharmacology and Pharmaceutical Chemistry, 3Department of Biology, College of Pharmacy, Riyadh Colleges of Dentistry and Pharmacy,
Sakr FM, Gado AMI, Mohammed HR, Adam ANI
doaj +1 more source
Minoxidil (U-10,858) has been shown in several controlled and blind studies and numerous uncontrolled studies to be a potent peripheral vasodilator for use in the management of sustained, severe, accelerating or malignant hypertension and moderate hypertension inadequately controlled by conventional therapy.
+6 more sources
Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability [PDF]
BACKGROUND: Topical minoxidil is the only US FDA-approved drug for the treatment of female pattern hair loss (FPHL). While the safety profile of topical minoxidil is excellent, the efficacy of minoxidil in hair growth is extremely low. A recent survey of
Mirna Situm +15 more
core +1 more source

